Setchell KD - Search Results

1

Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults.

Setchell KD, Brown NM, Summer S, King EC, Heubi JE, Cole S, Guy T, Hokin B. Setchell KD, et al. J Nutr. 2013 Dec;143(12):1950-8. doi: 10.3945/jn.113.179564. Epub 2013 Oct 2. J Nutr. 2013. PMID: 24089421 Free PMC article.

2

S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.

Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE. Setchell KD, et al. Am J Clin Nutr. 2005 May;81(5):1072-9. doi: 10.1093/ajcn/81.5.1072. Am J Clin Nutr. 2005. PMID: 15883431 Free article. Clinical Trial.

3

Method of defining equol-producer status and its frequency among vegetarians.

Setchell KD, Cole SJ. Setchell KD, et al. J Nutr. 2006 Aug;136(8):2188-93. doi: 10.1093/jn/136.8.2188. J Nutr. 2006. PMID: 16857839 Free article. Clinical Trial.

4

The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

Setchell KD, Zhao X, Jha P, Heubi JE, Brown NM. Setchell KD, et al. Am J Clin Nutr. 2009 Oct;90(4):1029-37. doi: 10.3945/ajcn.2009.27981. Epub 2009 Aug 26. Am J Clin Nutr. 2009. PMID: 19710188 Free PMC article. Clinical Trial.

5

Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.

Setchell KD, Brown NM, Zhao X, Lindley SL, Heubi JE, King EC, Messina MJ. Setchell KD, et al. Am J Clin Nutr. 2011 Nov;94(5):1284-94. doi: 10.3945/ajcn.111.019638. Epub 2011 Sep 28. Am J Clin Nutr. 2011. PMID: 21955647 Free PMC article. Clinical Trial.

6

S-(-)equol production is developmentally regulated and related to early diet composition.

Brown NM, Galandi SL, Summer SS, Zhao X, Heubi JE, King EC, Setchell KD. Brown NM, et al. Among authors: setchell kd. Nutr Res. 2014 May;34(5):401-9. doi: 10.1016/j.nutres.2014.03.005. Epub 2014 Apr 5. Nutr Res. 2014. PMID: 24916553 Free PMC article.

7

Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability.

Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Setchell KD, et al. Am J Clin Nutr. 2002 Aug;76(2):447-53. doi: 10.1093/ajcn/76.2.447. Am J Clin Nutr. 2002. PMID: 12145021 Clinical Trial.

8

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E. Setchell KD, et al. J Nutr. 2002 Dec;132(12):3577-84. doi: 10.1093/jn/132.12.3577. J Nutr. 2002. PMID: 12468591 Review.

9

Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.

Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE. Setchell KD, et al. J Nutr. 2003 Apr;133(4):1027-35. doi: 10.1093/jn/133.4.1027. J Nutr. 2003. PMID: 12672914

10

Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.

Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Setchell KD, et al. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1453S-1461S. doi: 10.1093/ajcn/68.6.1453S. Am J Clin Nutr. 1998. PMID: 9848516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters